RespireRx Pharmaceuticals Inc. Announces a Department of
Glen Rock, N.J., May 29, 2024 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Pink Markets: RSPI) (RespireRx or the Company), focused on the...
Source: globenewswire.com
Arnold Lippa News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Arnold Lippa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Arnold Lippa Today - Breaking & Trending Today
New Agreement to Boost Dronabinol OSA Drug Development
ResolutionRx Ltd entered into an agreement with Ab Initio Pharma to manufacture and test a dronabinol lipid nanoparticle formulation for OSA.
Source: sleepreviewmag.com
Today's Top OTC Stocks Watchlist (SWISF, EPAZ, ABQQ, RSPI)
Active stocks, known for their frequent price shifts and sustained market interest, are a magnet for savvy investors seeking profits. Let's take a closer look at some of the top OTC stocks from this...
Source: marketscreener.com
RespireRx to transfer cannabinoid research program to Australian subsidiary ResolutionRx
RespireRx Pharmaceuticals (OTC:RSPI) shares rose on Wednesday morning after it announced that it has entered into agreements with its Australian subsidiary...
Source: proactiveinvestors.com
ResolutionRx Secures $3.1M for OSA Drug Clinical Trial R&D
ResolutionRx secured $3.1 million in financing to support clinical trial R&D for a new formulation of dronabinol for the treatment of OSA.
Source: sleepreviewmag.com